INVA Therapies Named Finalists for Prix Galien USA Award
Innoviva Specialty Therapeutics' XACDURO, ZEVTERA, and NUZOLVENCE are finalists for the Prix Galien USA Best Pharmaceutical Product Award
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Innoviva Therapies Named Finalists
Innoviva's XACDURO, ZEVTERA, and NUZOLVENCE are finalists for the Prix Galien USA award